Avenue Therapeutics Stock Investor Sentiment

ATXI Stock  USD 0.38  0.04  9.52%   
Under 66% of Avenue Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Avenue Therapeutics stock suggests that many investors are alarmed at this time. Avenue Therapeutics' investing sentiment shows overall attitude of investors towards Avenue Therapeutics.
  

Avenue Therapeutics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Avenue Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
2 days ago at news.google.com         
12 Health Care Stocks Moving In Tuesdays Intraday Session - Benzinga
Google News at Macroaxis
few days ago at thelincolnianonline.com         
Avenue Therapeutics, Inc. Short Interest Down 35.2 percent in February
news
few days ago at news.google.com         
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview - TradingView
Google News at Macroaxis
six days ago at news.google.com         
Avenue Therapeutics stock hits 52-week low at 0.9 amid downturn - Investing.com
Google News at Macroaxis
over a week ago at news.google.com         
Avenue Therapeutics granted Nasdaq extension, faces AnnJi dispute - Investing.com India
Google News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Financial Review Teva Pharmaceutical Industries and Avenue Therapeutics
news
over two weeks ago at news.google.com         
Avenue Therapeutics, Inc. Short Interest Down 40.5 percent in February - Defense World
Google News at Macroaxis
over two weeks ago at news.google.com         
Avenue Therapeutics stock hits 52-week low at 1.22 - Investing.com
Google News at Macroaxis
over two weeks ago at www.macroaxis.com         
Acquisition by Herskowitz Neil of 2500 shares of Avenue Therapeutics at 3.99 subject to Rule 16b-3
Macroaxis News
over a month ago at gurufocus.com         
ARMISTICE CAPITAL, LLC Adjusts Holdings in Avenue Therapeutics Inc
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
Avenue Therapeutics, Inc. Short Interest Up 92.2 percent in January
news
over a month ago at news.google.com         
The Surprise Surge How Travere Therapeutics Defied Wall Street Trends - Jomfruland.net
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
Avenue Therapeutics, Inc. Short Interest Update
news
over a month ago at news.google.com         
Avenue Therapeutics stock hits 52-week low at 1.5 amid challenges - Investing.com
Google News at Macroaxis
over two months ago at www.macroaxis.com         
Insider Trading
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Avenue Therapeutics that are available to investors today. That information is available publicly through Avenue media outlets and privately through word of mouth or via Avenue internal channels. However, regardless of the origin, that massive amount of Avenue data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Avenue Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Avenue Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Avenue Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Avenue Therapeutics alpha.

Avenue Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Insider Trading
12/31/2024
2
Avenue Therapeutics, Inc. Short Interest Update
01/31/2025
3
Acquisition by Herskowitz Neil of 2500 shares of Avenue Therapeutics at 3.99 subject to Rule 16b-3
02/26/2025
4
Avenue Therapeutics stock hits 52-week low at 0.9 amid downturn - Investing.com
03/13/2025
5
12 Health Care Stocks Moving In Tuesdays Intraday Session - Benzinga
03/18/2025

Complementary Tools for Avenue Stock analysis

When running Avenue Therapeutics' price analysis, check to measure Avenue Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avenue Therapeutics is operating at the current time. Most of Avenue Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avenue Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avenue Therapeutics' price. Additionally, you may evaluate how the addition of Avenue Therapeutics to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.